175 related articles for article (PubMed ID: 38011562)
21. Expression and function of FRA1 protein in tumors.
Jiang X; Xie H; Dou Y; Yuan J; Zeng D; Xiao S
Mol Biol Rep; 2020 Jan; 47(1):737-752. PubMed ID: 31612408
[TBL] [Abstract][Full Text] [Related]
22. The AP-1 transcription factor Fra1 inhibits follicular B cell differentiation into plasma cells.
Grötsch B; Brachs S; Lang C; Luther J; Derer A; Schlötzer-Schrehardt U; Bozec A; Fillatreau S; Berberich I; Hobeika E; Reth M; Wagner EF; Schett G; Mielenz D; David JP
J Exp Med; 2014 Oct; 211(11):2199-212. PubMed ID: 25288397
[TBL] [Abstract][Full Text] [Related]
23. ADP-Ribosylation, a Multifaceted Posttranslational Modification Involved in the Control of Cell Physiology in Health and Disease.
Lüscher B; Bütepage M; Eckei L; Krieg S; Verheugd P; Shilton BH
Chem Rev; 2018 Feb; 118(3):1092-1136. PubMed ID: 29172462
[TBL] [Abstract][Full Text] [Related]
24. FRA1 promotes squamous cell carcinoma growth and metastasis through distinct AKT and c-Jun dependent mechanisms.
Zhang X; Wu J; Luo S; Lechler T; Zhang JY
Oncotarget; 2016 Jun; 7(23):34371-83. PubMed ID: 27144339
[TBL] [Abstract][Full Text] [Related]
25. Role of a TRIM72 ADP-ribosylation cycle in myocardial injury and membrane repair.
Ishiwata-Endo H; Kato J; Tonouchi A; Chung YW; Sun J; Stevens LA; Zhu J; Aponte AM; Springer DA; San H; Takeda K; Yu ZX; Hoffmann V; Murphy E; Moss J
JCI Insight; 2018 Nov; 3(22):. PubMed ID: 30429362
[TBL] [Abstract][Full Text] [Related]
26. Auto ADP-ribosylation of NarE, a Neisseria meningitidis ADP-ribosyltransferase, regulates its catalytic activities.
Picchianti M; Del Vecchio M; Di Marcello F; Biagini M; Veggi D; Norais N; Rappuoli R; Pizza M; Balducci E
FASEB J; 2013 Dec; 27(12):4723-30. PubMed ID: 23964075
[TBL] [Abstract][Full Text] [Related]
27. Discovery of highly potent PARP7 inhibitors for cancer immunotherapy.
Yang J; Liu B; Yan W; Zhao X; Wang C; Zhu Q; Zou Y; Xu Y; Gu H
Bioorg Chem; 2024 Jul; 148():107469. PubMed ID: 38781669
[TBL] [Abstract][Full Text] [Related]
28. Discovery of Highly Selective PARP7 Inhibitors with a Novel Scaffold for Cancer Immunotherapy.
Gu H; Yan W; Yang J; Liu B; Zhao X; Wang H; Xu W; Wang C; Chen Y; Dong Q; Zhu Q; Xu Y; Zou Y
J Med Chem; 2024 Feb; 67(3):1932-1948. PubMed ID: 38059836
[TBL] [Abstract][Full Text] [Related]
29. Roles of the ubiquitin ligase CUL4B and ADP-ribosyltransferase TiPARP in TCDD-induced nuclear export and proteasomal degradation of the transcription factor AHR.
Rijo MP; Diani-Moore S; Yang C; Zhou P; Rifkind AB
J Biol Chem; 2021 Aug; 297(2):100886. PubMed ID: 34146543
[TBL] [Abstract][Full Text] [Related]
30. Chemical genetics and proteome-wide site mapping reveal cysteine MARylation by PARP-7 on immune-relevant protein targets.
Rodriguez KM; Buch-Larsen SC; Kirby IT; Siordia IR; Hutin D; Rasmussen M; Grant DM; David LL; Matthews J; Nielsen ML; Cohen MS
Elife; 2021 Jan; 10():. PubMed ID: 33475084
[TBL] [Abstract][Full Text] [Related]
31. TiPARP forms nuclear condensates to degrade HIF-1α and suppress tumorigenesis.
Zhang L; Cao J; Dong L; Lin H
Proc Natl Acad Sci U S A; 2020 Jun; 117(24):13447-13456. PubMed ID: 32482854
[TBL] [Abstract][Full Text] [Related]
32. A Cell-Line-Specific Atlas of PARP-Mediated Protein Asp/Glu-ADP-Ribosylation in Breast Cancer.
Zhen Y; Zhang Y; Yu Y
Cell Rep; 2017 Nov; 21(8):2326-2337. PubMed ID: 29166620
[TBL] [Abstract][Full Text] [Related]
33. Discovery of the Potent and Highly Selective PARP7 Inhibitor as a Novel Immunotherapeutic Agent for Tumors.
Gu H; Yan W; Wang Y; Xu W; Huang L; Yang J; Zhai B; Wang H; Su Y; Zhu Q; Liu B; Hao H; Zou Y; Xu Y
J Med Chem; 2023 Jan; 66(1):473-490. PubMed ID: 36576395
[TBL] [Abstract][Full Text] [Related]
34. Enabling drug discovery for the PARP protein family through the detection of mono-ADP-ribosylation.
Lu AZ; Abo R; Ren Y; Gui B; Mo JR; Blackwell D; Wigle T; Keilhack H; Niepel M
Biochem Pharmacol; 2019 Sep; 167():97-106. PubMed ID: 31075269
[TBL] [Abstract][Full Text] [Related]
35. PKD-dependent PARP12-catalyzed mono-ADP-ribosylation of Golgin-97 is required for E-cadherin transport from Golgi to plasma membrane.
Grimaldi G; Filograna A; Schembri L; Lo Monte M; Di Martino R; Pirozzi M; Spano D; Beccari AR; Parashuraman S; Luini A; Valente C; Corda D
Proc Natl Acad Sci U S A; 2022 Jan; 119(1):. PubMed ID: 34969853
[TBL] [Abstract][Full Text] [Related]
36. Biochemical characterization of mono ADP ribosyl transferase activity of human sirtuin SIRT7 and its regulation.
Mitra N; Dey S
Arch Biochem Biophys; 2020 Feb; 680():108226. PubMed ID: 31843644
[TBL] [Abstract][Full Text] [Related]
37. Small-Molecule Chemical Probe Rescues Cells from Mono-ADP-Ribosyltransferase ARTD10/PARP10-Induced Apoptosis and Sensitizes Cancer Cells to DNA Damage.
Venkannagari H; Verheugd P; Koivunen J; Haikarainen T; Obaji E; Ashok Y; Narwal M; Pihlajaniemi T; Lüscher B; Lehtiö L
Cell Chem Biol; 2016 Oct; 23(10):1251-1260. PubMed ID: 27667561
[TBL] [Abstract][Full Text] [Related]
38. BAL1/ARTD9 represses the anti-proliferative and pro-apoptotic IFNγ-STAT1-IRF1-p53 axis in diffuse large B-cell lymphoma.
Camicia R; Bachmann SB; Winkler HC; Beer M; Tinguely M; Haralambieva E; Hassa PO
J Cell Sci; 2013 May; 126(Pt 9):1969-80. PubMed ID: 23487038
[TBL] [Abstract][Full Text] [Related]
39. CagL from Helicobacter pylori has ADP-ribosylation activity and exerts partial protective efficacy in mice.
Talluri E; Pancotto L; Ruggiero P; Scarselli M; Balducci E
Arch Biochem Biophys; 2017 Dec; 635():102-109. PubMed ID: 29097311
[TBL] [Abstract][Full Text] [Related]
40. Mono-ADP-Ribosylation Catalyzed by Arginine-Specific ADP-Ribosyltransferases.
Stevens LA; Moss J
Methods Mol Biol; 2018; 1813():149-165. PubMed ID: 30097866
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
